Cargando…
Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643571/ https://www.ncbi.nlm.nih.gov/pubmed/25417969 http://dx.doi.org/10.1007/s00415-014-7565-7 |
| _version_ | 1782400538896236544 |
|---|---|
| author | Ziemssen, Tjalf Bajenaru, Ovidiu A. Carrá, Adriana de Klippel, Nina Correia de Sá, João Edland, Astrid Frederiksen, Jette L. Heinzlef, Olivier Karageorgiou, Klimentini E. Lander Delgado, Rafael H. Landtblom, Anne-Marie Macías Islas, Miguel A. Tubridy, Niall Gilgun-Sherki, Yossi |
| author_facet | Ziemssen, Tjalf Bajenaru, Ovidiu A. Carrá, Adriana de Klippel, Nina Correia de Sá, João Edland, Astrid Frederiksen, Jette L. Heinzlef, Olivier Karageorgiou, Klimentini E. Lander Delgado, Rafael H. Landtblom, Anne-Marie Macías Islas, Miguel A. Tubridy, Niall Gilgun-Sherki, Yossi |
| author_sort | Ziemssen, Tjalf |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4643571 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46435712015-11-19 Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial Ziemssen, Tjalf Bajenaru, Ovidiu A. Carrá, Adriana de Klippel, Nina Correia de Sá, João Edland, Astrid Frederiksen, Jette L. Heinzlef, Olivier Karageorgiou, Klimentini E. Lander Delgado, Rafael H. Landtblom, Anne-Marie Macías Islas, Miguel A. Tubridy, Niall Gilgun-Sherki, Yossi J Neurol Erratum Springer Berlin Heidelberg 2014-11-25 2015 /pmc/articles/PMC4643571/ /pubmed/25417969 http://dx.doi.org/10.1007/s00415-014-7565-7 Text en © Springer-Verlag Berlin Heidelberg 2014 |
| spellingShingle | Erratum Ziemssen, Tjalf Bajenaru, Ovidiu A. Carrá, Adriana de Klippel, Nina Correia de Sá, João Edland, Astrid Frederiksen, Jette L. Heinzlef, Olivier Karageorgiou, Klimentini E. Lander Delgado, Rafael H. Landtblom, Anne-Marie Macías Islas, Miguel A. Tubridy, Niall Gilgun-Sherki, Yossi Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial |
| title | Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial |
| title_full | Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial |
| title_fullStr | Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial |
| title_full_unstemmed | Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial |
| title_short | Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial |
| title_sort | erratum to: a 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the coptimize trial |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643571/ https://www.ncbi.nlm.nih.gov/pubmed/25417969 http://dx.doi.org/10.1007/s00415-014-7565-7 |
| work_keys_str_mv | AT ziemssentjalf erratumtoa2yearobservationalstudyofpatientswithrelapsingremittingmultiplesclerosisconvertingtoglatirameracetatefromotherdiseasemodifyingtherapiesthecoptimizetrial AT bajenaruovidiua erratumtoa2yearobservationalstudyofpatientswithrelapsingremittingmultiplesclerosisconvertingtoglatirameracetatefromotherdiseasemodifyingtherapiesthecoptimizetrial AT carraadriana erratumtoa2yearobservationalstudyofpatientswithrelapsingremittingmultiplesclerosisconvertingtoglatirameracetatefromotherdiseasemodifyingtherapiesthecoptimizetrial AT deklippelnina erratumtoa2yearobservationalstudyofpatientswithrelapsingremittingmultiplesclerosisconvertingtoglatirameracetatefromotherdiseasemodifyingtherapiesthecoptimizetrial AT correiadesajoao erratumtoa2yearobservationalstudyofpatientswithrelapsingremittingmultiplesclerosisconvertingtoglatirameracetatefromotherdiseasemodifyingtherapiesthecoptimizetrial AT edlandastrid erratumtoa2yearobservationalstudyofpatientswithrelapsingremittingmultiplesclerosisconvertingtoglatirameracetatefromotherdiseasemodifyingtherapiesthecoptimizetrial AT frederiksenjettel erratumtoa2yearobservationalstudyofpatientswithrelapsingremittingmultiplesclerosisconvertingtoglatirameracetatefromotherdiseasemodifyingtherapiesthecoptimizetrial AT heinzlefolivier erratumtoa2yearobservationalstudyofpatientswithrelapsingremittingmultiplesclerosisconvertingtoglatirameracetatefromotherdiseasemodifyingtherapiesthecoptimizetrial AT karageorgiouklimentinie erratumtoa2yearobservationalstudyofpatientswithrelapsingremittingmultiplesclerosisconvertingtoglatirameracetatefromotherdiseasemodifyingtherapiesthecoptimizetrial AT landerdelgadorafaelh erratumtoa2yearobservationalstudyofpatientswithrelapsingremittingmultiplesclerosisconvertingtoglatirameracetatefromotherdiseasemodifyingtherapiesthecoptimizetrial AT landtblomannemarie erratumtoa2yearobservationalstudyofpatientswithrelapsingremittingmultiplesclerosisconvertingtoglatirameracetatefromotherdiseasemodifyingtherapiesthecoptimizetrial AT maciasislasmiguela erratumtoa2yearobservationalstudyofpatientswithrelapsingremittingmultiplesclerosisconvertingtoglatirameracetatefromotherdiseasemodifyingtherapiesthecoptimizetrial AT tubridyniall erratumtoa2yearobservationalstudyofpatientswithrelapsingremittingmultiplesclerosisconvertingtoglatirameracetatefromotherdiseasemodifyingtherapiesthecoptimizetrial AT gilgunsherkiyossi erratumtoa2yearobservationalstudyofpatientswithrelapsingremittingmultiplesclerosisconvertingtoglatirameracetatefromotherdiseasemodifyingtherapiesthecoptimizetrial |